A 6-month trial of pergolide mesylate in the treatment of idiopathic Parkinson's disease.
D002986:Clinical Trials as Topic; D004185:Disability Evaluation; D004873:Ergolines / Q000008:administration & dosage / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007980:Levodopa / Q000008:administration & dosage / Q000009:adverse effects; D008297:Male; D010300:Parkinson Disease / Q000188:drug therapy* / Q000209:etiology; D010479:Pergolide; D012890:Sleep / Q000187:drug effects; D013997:Time Factors
D004873:Ergolines; D010479:Pergolide; D007980:Levodopa